[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].

Klos, Krzysztof; Kruszewski, Jerzy; Kruszewski, Robert; Sulek, Kazimierz

[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial]. / Wplyw 5-dniowego stosowania zalecanych dawek cetyryzyny, desloratadyny, feksofenadyny 120 i 180 mg, lewocetyryzyny i loratadyny na pohistaminowa reaktwnosc skóry i przeplyw wltsniczkowy - badanie randomizowane, kontrolowane placebo.

Klos, Krzysztof; Kruszewski, Jerzy; Kruszewski, Robert; Sulek, Kazimierz.

Affiliation

Klos K; Department of Infectious Diseases and Allergology, Military Institute of the Heath Service in Warsaw, Central Clinical Hospital of the Ministry of National Defence. krzysztofandklos@poczta.onet.pl

Pol Merkur Lekarski ; 21(125): 449-53, 2006 Nov.

Article in Pl | MEDLINE | ID: mdl-17345838

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin / Urticaria / Histamine H1 Antagonists, Non-Sedating Type of study: Clinical_trials Limits: Adult / Humans / Male Language: Pl Journal: Pol Merkur Lekarski Journal subject: MEDICINA Year: 2006 Document type: Article Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links